Pimozide Tablets

Form: Oral Tablets

Strength: 1 mg, 2 mg, 4 mg

Reference Brands: Orap®(US & EU)

Category: Antipsychotropic Drugs

Pimozide tablets are FDA-approved in the United States for treating Tourette’s syndrome and are also indicated for chronic schizophrenia in select markets. In the EU, they are approved under strict guidelines for use in resistant schizophrenia and tic disorders. Both regions require compliance with GMP, pharmacovigilance, and detailed psychiatric safety data, especially concerning cardiac risks (QT prolongation). Registration demands a complete dossier including clinical data and labeling per FDA and EMA standards. To explore dossier-ready Pimozide tablets, APIs, and other available forms, visit Pharmatradz.com — your trusted B2B source for global pharmaceutical products.